Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aridis Pharmaceuticals Inc.

0.0001
+0.0000
Volume:- -
Turnover:- -
Market Cap:4.46K
PE:0.00
High:0.0001
Open:0.0001
Low:0.0001
Close:0.0001
Loading ...

Healios Advances MultiStem Approval for ARDS in Japan

TIPRANKS
·
15 Jan

3 US Penny Stocks With Market Caps Under $200M To Consider

Simply Wall St.
·
15 Jan

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

PR Newswire
·
14 Jan

Healios Nears Japan Approval for ARDS Treatment

MT Newswires Live
·
27 Dec 2024

Healios KK Advances ARDS Treatment Approval

TIPRANKS
·
26 Dec 2024

Aridis Pharmaceuticals continuing to explore ‘multiple paths to monetize’ assets

TIPRANKS
·
20 Dec 2024

Aridis Provides Corporate Update

THOMSON REUTERS
·
20 Dec 2024

Aridis Provides Corporate Update

GlobeNewswire
·
20 Dec 2024

US Penny Stocks To Consider In December 2024

Simply Wall St.
·
17 Dec 2024

Press Release: Edesa Biotech Reports Fiscal Year 2024 Results

Dow Jones
·
14 Dec 2024

XORTX Announces Presentation at the Rare and Genetic Disease Summit

GlobeNewswire
·
12 Dec 2024

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

GlobeNewswire
·
11 Dec 2024

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

GlobeNewswire
·
06 Dec 2024

CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

PR Newswire
·
05 Dec 2024

InflaRx receives positive CHMP opinion for GOHIBIC for SARS-CoV-2-induced ARDS

TIPRANKS
·
15 Nov 2024

InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

GlobeNewswire
·
15 Nov 2024